BICALUTAMIDE ACCORD
BICALUTAMIDE
Public price
456,00 MAD
Active substance
BICALUTAMIDE
Laboratory
PHARMIS
What is this medicine?
Bicalutamide is a non-steroidal androgen receptor inhibitor used for the treatment of prostate cancer.
Verified summary
BICALUTAMIDE, COMPRIME PELLICULE, 50 MG, BOITE DE 28
Common uses
Used in combination therapy with a luteinizing hormone-releasing hormone (LHRH) analog for the treatment of Stage D 2 metastatic carcinoma of the prostate.
Class
Non-steroidal androgen receptor inhibitor
Laboratory
PHARMIS
Hospital price
303,00 MAD
Strength
50 MG
Form
COMPRIME PELLICULE
Presentation
BOITE DE 28
Commercial status
Retiré du Marché
This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2026-06-01: 456,00 MAD
Medicines with the same active substance
BICALUTAMIDE GT
150 MG · BOITE DE 20
1,14 MAD
BICALUTAMIDE ZENITH
150 MG · BOITE DE 30
1,26 MAD
BICALUTAMIDE GT
150 MG · BOITE DE 60
2,58 MAD
BICALUTAMIDE ZENITH
50 MG · BOITE DE 10
197,10 MAD
BICALUTAMIDE ZENITH 50 MG
50 MG · Boite 10
197,10 MAD
BICALUTAMIDE GT
50 MG · BOITE DE 20
326,00 MAD
BICALUTAMIDE PHARMED
50 MG · BOITE DE 28
434,00 MAD
BICALUTAMIDE PHARMED 50 MG
50 MG · Boite de 28
434,00 MAD
PROTADEX
50 MG · BOITE DE 28
449,00 MAD
PROTADEX 50 MG
50 MG · Boite de 28
449,00 MAD
BICALUTAMIDE GT
50 MG · 1 BOITE 20 COMPRIME PELLICULE
450,00 MAD
BICALUTAMIDE COOPER
50 MG · BOITE DE 30
478,00 MAD